Oscillating Positive Expiratory Pressure Devices Market - Forecast to 2032 | Global Insight Services


Posted April 12, 2024 by KabitaSahu

Oscillating Positive Expiratory Pressure Devices Market Analysis and Forecast to 2032: By Product Type, Indication (COPD & Asthma, Bronchitis, Cystic Fibrosis, Others), End-user, and Region
 
The oscillating positive expiratory pressure devices market was valued at USD 125.7 million in 2022 and it is anticipated to grow further till USD 208.9 million by 2032, at a CAGR of 5.2% during the forecast period.

Know More- https://www.globalinsightservices.com/reports/oscillating-positive-expiratory-pressure-devices-market/

The machines that are utilized to remove secretions from the airways are known as oscillating positive expiratory pressure (OPEP) devices. People with chronic respiratory conditions like COPD, cystic fibrosis, and chronic bronchitis among others can benefit from it. The device is used to remove excess mucus that these illnesses produce. It facilitates breathing and helps to relax the lungs’ walls.


Major Players in the Global Oscillating Positive Expiratory Pressure Devices Market

The major players studied in the global oscillating positive expiratory pressure devices market are AirPhysio, Allergan plc., D-R Burton Healthcare, Medica Holdings, LLC., Monaghan Medical Corporation, PARI GmbH, R. Cegla GmbH & Co. KG, Smiths Medical, Inc., and WyMedical Pty Ltd among others.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By GIS
Country India
Categories Biotech
Last Updated April 12, 2024